Open AccessAnti‐PD1 or anti‐PD‐L1 antibodies alone or in combination with chemotherapy first‐line treatment of advanced non‐small cell lung cancer
Author(s) -
Zhang Xuexia,
Cai Xiaoping,
Zheng Hao
Publication year - 2022
Publication title -
thoracic cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.823
H-Index - 28
eISSN - 1759-7714
pISSN - 1759-7706
DOI - 10.1111/1759-7714.14358
Subject(s) - medicine , oncology , lung cancer , chemotherapy , immunotherapy , chemoradiotherapy , cancer